P3. 02c-011 A Phase 1b Open-Label Study of PEGPH20 Combined with Pembrolizumab in Patients with Selected Hyaluronan-High Solid Tumors: Topic: Targeted Therapy
Journal article published in 2017 by
Philip Gold,
R. Donald Harvey 
,
Alexander Spira,
Lyudmila Bazhenova,
John Nemunaitis,
Joaquina Baranda,
Shirish Gadgeel
,
Alexander Spira,
Lyudmila Bazhenova,
John Nemunaitis,
Joaquina Baranda,
Shirish Gadgeel
